Fin
Echo
Markets
Dashboard
Search
Fear & Greed
Tools
Watchlist
Budget
Context
Upcoming
Notifications
Upcoming
Research
News
Market Events
Economy
New
SEC Filings
Finecho Content
New
Fin
Echo
Markets
Dashboard
Search
Fear & Greed
Tools
Watchlist
Budget
Context
Upcoming
Notifications
Upcoming
Research
News
Market Events
Economy
New
SEC Filings
Finecho Content
New
GOLDAN KEITH A.
Private
CIK: 1495411
Location
CONSHOHOCKEN, PA
Insider Of
3
Name & Role
Position
Tenure
Holdings
SYNDAX PHARMACEUTICALS INC
Chief Financial Officer
Since Jun 2022
—
OPTINOSE, INC.
Chief Financial Officer
Since Feb 2019
—
ABEONA THERAPEUTICS INC.
—
Since Apr 2026
—
SYNDAX PHARMACEUTICALS INC
Position
Chief Financial Officer
Tenure
Since Jun 2022
Holdings
—
OPTINOSE, INC.
Position
Chief Financial Officer
Tenure
Since Feb 2019
Holdings
—
ABEONA THERAPEUTICS INC.
Position
—
Tenure
Since Apr 2026
Holdings
—